| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-09 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |